home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

100.68 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

56 57 Next >

This Is What Whales Are Betting On Abbott Laboratories ↗

January 27, 2025

Via Benzinga

Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here' ↗

January 27, 2025

Cramer takes a look at TETRA Technologies, Abbott, Wendy's, Nu Holdings and Casella Waste on the latest edition of "Mad Money."

Via Benzinga

Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday ↗

January 27, 2025

Via Benzinga

Market Whales and Their Recent Bets on ABT Options ↗

January 24, 2025

Via Benzinga

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

January 24, 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Via MarketBeat

Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings) ↗

January 23, 2025

Via Benzinga

Why Is Abbott Stock Trading Higher On Thursday? ↗

January 23, 2025

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.

Via Benzinga

Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock ↗

January 23, 2025

Via Benzinga

US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focus ↗

January 23, 2025

U.S. stock futures were mixed on Thursday following Wednesday's rally. Futures of benchmark indices were lower except Dow Jones.

Via Benzinga

Topics Stocks

My Top 5 Stocks to Buy in Early 2025 ↗

January 23, 2025

Via The Motley Fool

S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone ↗

January 23, 2025

Via Benzinga

Topics Stocks

S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run ↗

January 22, 2025

Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks.

Via Benzinga

Topics Artificial Intelligence Government Stocks

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales ↗

January 22, 2025

Via Benzinga

Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript ↗

January 22, 2025

ABT earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall ↗

January 22, 2025

Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices.

Via Benzinga

Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday? ↗

January 22, 2025

Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp.

Via Benzinga

Topics Artificial Intelligence Government

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit ↗

January 22, 2025

The company expects to earn an adjusted $5.05 to $5.25 per share this year, in line with forecasts for $5.16.

Via Investor's Business Daily

US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch ↗

January 22, 2025

U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday.

Via Benzinga

Topics Artificial Intelligence Government

Earnings Scheduled For January 22, 2025 ↗

January 22, 2025

Via Benzinga

Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗

January 22, 2025

The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks.

Via Benzinga

Topics Government Stocks

Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday ↗

January 22, 2025

Via Benzinga

Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever ↗

January 21, 2025

Via The Motley Fool

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗

January 21, 2025

Via The Motley Fool

3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever ↗

January 21, 2025

Via The Motley Fool

FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch ↗

January 15, 2025

The U.S. Food and Drug Administration announced a ban on Red No. 3, an artificial food coloring linked to cancer in animal studies, effective Jan. 15, 2027.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 14, 2025

Via Benzinga

3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees ↗

January 14, 2025

Via The Motley Fool

8 Health Care Stocks Whale Activity In Today's Session ↗

January 08, 2025

Via Benzinga

Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst ↗

January 07, 2025

Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030.

Via Benzinga

2 No-Brainer Dividend Stocks to Buy With $250 in 2025 ↗

January 06, 2025

Via The Motley Fool

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com